Argenx wins FDA nod to broaden Vyvgart label in myasthenia gravis
argenx SE American Depositary Shares · Now $836.09
+4.0% in 1d after detection
Post-detection moves
1h
—
1d
+4.0%
3d
+2.6%
7d
+2.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS